EUVIMEDEUVIMED entdecken
Crossref

The ability of magnetic resonance imaging to predict lymph node metastases and the risk of recurrence in rectal cancer

Taru M Lehtonen, Anna Ilvesmäki, Laura E Koskenvuo, Anna H Lepistö

Journal of Surgical Oncology · 2023

DOI: 10.1002/jso.27216 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2023. Verfasst von Taru M Lehtonen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Helsinki University Hospital (HUS), University of Helsinki, Helsinki, Finland. Hauptthemen laut MEDLINE: Rectal Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: Helsingin ja Uudenmaan Sairaanhoitopiiri.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

This study aimed to examine the diagnostic accuracy and prognostic value of magnetic resonance imaging (MRI) detected lymph nodes in rectal cancer.

Method

We evaluated 806 rectal cancer patients consecutively operated on between 2015 and 2018 at Helsinki University Hospital. In total, 485 patients met the inclusion criteria of presenting with stage I–III disease and were intended for curative treatment at the time of diagnosis. The effect of MRI‐detected clinical lymph node status (cN) on cumulative overall survival (OS), disease‐specific survival (DSS) and disease‐free survival (DFS) was calculated using the Kaplan–Meier analysis.

Results

Negative predictive value (NPV) of MRI‐lymphnode negativity was 74.8%. Positive predictive value of lymph node metastasis was only 48.6%. In the Kaplan–Meier survival analysis, OS ( p = 0.989), DSS ( p = 0.911), and DFS (p = 0.109) did not significantly differ according to MRI nodal status. However, cumulative disease‐free survival significantly ( p < 0.001) differed according to the histopathological lymph node metastasis status (pN).

Conclusions

MRI detected lymph node positivity appears insufficiently precise and cannot predict disease recurrence or survival. Therefore, it should not serve as an independent risk factor when considering neoadjuvant treatment options for rectal cancer patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rectal NeoplasmsHumansLymphatic MetastasisLymph NodesPrognosisDisease-Free SurvivalMagnetic Resonance ImagingNeoplasm StagingLymph Node ExcisionRetrospective Studies

Stichwörter der Autor:innen

lymph node metastasesmagnetic resonance imagingrectal cancer

Autor:innen und Institutionen

  • Department of Surgery, Helsinki University Hospital (HUS), University of Helsinki, Helsinki, Finland.
  • Applied Tumour Genomics, Research Programmes Unit, University of Helsinki, Helsinki, Finland.

Förderung

  • Helsingin ja Uudenmaan Sairaanhoitopiiri

Zitieren

APA

Lehtonen, T. M., Ilvesmäki, A., Koskenvuo, L. E., & Lepistö, A. H. (2023). The ability of magnetic resonance imaging to predict lymph node metastases and the risk of recurrence in rectal cancer. Journal of Surgical Oncology. https://doi.org/10.1002/jso.27216

Vancouver

Lehtonen TM, Ilvesmäki A, Koskenvuo LE, Lepistö AH. The ability of magnetic resonance imaging to predict lymph node metastases and the risk of recurrence in rectal cancer. Journal of Surgical Oncology. 2023. doi:10.1002/jso.27216

BibTeX
@article{Lehtonen2023,
  author = {Lehtonen, Taru M and Ilvesmäki, Anna and Koskenvuo, Laura E and Lepistö, Anna H},
  title = {The ability of magnetic resonance imaging to predict lymph node metastases and the risk of recurrence in rectal cancer},
  journal = {Journal of Surgical Oncology},
  year = {2023},
  doi = {10.1002/jso.27216}
}
Kostenlos starten →